These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37787635)

  • 1. A preoperative computed tomography radiomics model to predict disease-free survival in patients with pancreatic neuroendocrine tumors.
    Homps M; Soyer P; Coriat R; Dermine S; Pellat A; Fuks D; Marchese U; Terris B; Groussin L; Dohan A; Barat M
    Eur J Endocrinol; 2023 Oct; 189(4):476-484. PubMed ID: 37787635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
    Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
    Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature.
    Javed AA; Zhu Z; Kinny-Köster B; Habib JR; Kawamoto S; Hruban RH; Fishman EK; Wolfgang CL; He J; Chu LC
    Diagn Interv Imaging; 2024 Jan; 105(1):33-39. PubMed ID: 37598013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-Based Radiomics Score for Distinguishing Between Grade 1 and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Bian Y; Jiang H; Ma C; Wang L; Zheng J; Jin G; Lu J
    AJR Am J Roentgenol; 2020 Oct; 215(4):852-863. PubMed ID: 32755201
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative Prediction of G1 and G2/3 Grades in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging.
    Liu C; Bian Y; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Ma C; Lu J; Xu J; Shao C
    Acad Radiol; 2022 Apr; 29(4):e49-e60. PubMed ID: 34175209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.
    Ye JY; Fang P; Peng ZP; Huang XT; Xie JZ; Yin XY
    Eur Radiol; 2024 Mar; 34(3):1994-2005. PubMed ID: 37658884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model.
    Ahmed TM; Zhu Z; Yasrab M; Blanco A; Kawamoto S; He J; Fishman EK; Chu L; Javed AA
    Ann Surg Oncol; 2024 Nov; 31(12):8136-8145. PubMed ID: 39179862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram to preoperatively predict the aggressiveness of non-functional pancreatic neuroendocrine tumors based on CT features.
    Shen X; Yang F; Jiang T; Zheng Z; Chen Y; Tan C; Ke N; Qiu J; Liu X; Zhang H; Wang X
    Eur J Radiol; 2024 Feb; 171():111284. PubMed ID: 38232572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients.
    Krogh S; Grønbæk H; Knudsen AR; Kissmeyer-Nielsen P; Hummelshøj NE; Dam G
    Front Endocrinol (Lausanne); 2022; 13():925632. PubMed ID: 35837305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
    Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
    Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
    Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
    JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of pancreatic neuroendocrine tumor grade based on
    Ma J; Wang X; Tang M; Zhang C
    Endocrine; 2024 Feb; 83(2):502-510. PubMed ID: 37715934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
    Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
    Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection.
    Arai T; Kobayashi A; Fujinaga Y; Yokoyama T; Shimizu A; Motoyama H; Kitagawa N; Notake T; Shirota T; Fukushima K; Masuo H; Kadoya M; Miyagawa S
    Pancreatology; 2016; 16(3):397-402. PubMed ID: 26850565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special issue "The advance of solid tumor research in China": Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors.
    Chen L; Wang W; Jin K; Yuan B; Tan H; Sun J; Guo Y; Luo Y; Feng ST; Yu X; Chen MH; Chen J
    Int J Cancer; 2023 Jan; 152(1):90-99. PubMed ID: 36111424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
    Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
    Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics.
    Ma M; Gu W; Liang Y; Han X; Zhang M; Xu M; Gao H; Tang W; Huang D
    J Transl Med; 2024 Aug; 22(1):768. PubMed ID: 39143624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.